These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6725115)

  • 1. Histologic classification as an indication of therapeutic response in malignant lymphoma of dogs.
    Gray KN; Raulston GL; Gleiser CA; Jardine JH
    J Am Vet Med Assoc; 1984 Apr; 184(7):814-7. PubMed ID: 6725115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
    Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
    J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
    Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
    J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma.
    Simon D; Moreno SN; Hirschberger J; Moritz A; Kohn B; Neumann S; Jurina K; Scharvogel S; Schwedes C; Reinacher M; Beyerbach M; Nolte I
    J Am Vet Med Assoc; 2008 Mar; 232(6):879-85. PubMed ID: 18341445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs.
    Zenker I; Meichner K; Steinle K; Kessler M; Hirschberger J
    Vet Rec; 2010 Nov; 167(19):744-8. PubMed ID: 21257510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of relapsed canine lymphoma with doxorubicin and dacarbazine.
    Van Vechten M; Helfand SC; Jeglum KA
    J Vet Intern Med; 1990; 4(4):187-91. PubMed ID: 2401965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly administration of low-dose doxorubicin for treatment of malignant lymphoma in dogs.
    Ogilvie GK; Vail DM; Klein MK; Powers BE; Dickinson K
    J Am Vet Med Assoc; 1991 May; 198(10):1762-4. PubMed ID: 2071476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy.
    Ponce F; Magnol JP; Ledieu D; Marchal T; Turinelli V; Chalvet-Monfray K; Fournel-Fleury C
    Vet J; 2004 Mar; 167(2):158-66. PubMed ID: 14975390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro immune monitoring of antibody response in dogs given chemoimmunotherapy for lymphoma.
    Jeglum KA; Winters WD; Young KM
    Am J Vet Res; 1989 Apr; 50(4):488-92. PubMed ID: 2712415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of mitoxantrone for the treatment of lymphoma in dogs.
    Moore AS; Ogilvie GK; Ruslander D; Rand WS; Cotter SM; Getzy DM; L'Heureux DA; Dennis RA
    J Am Vet Med Assoc; 1994 Jun; 204(12):1903-5. PubMed ID: 8077132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-mobility group B1 proteins in canine lymphoma: prognostic value of initial and sequential serum levels in treatment outcome following combination chemotherapy.
    Meyer A; Eberle N; Bullerdiek J; Nolte I; Simon D
    Vet Comp Oncol; 2010 Jun; 8(2):127-37. PubMed ID: 20579326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is your diagnosis? Ocular lymphoma.
    Cave T; Billson M
    J Small Anim Pract; 2003 Dec; 44(12):523, 553-4. PubMed ID: 14692547
    [No Abstract]   [Full Text] [Related]  

  • 13. Intralymphatic autochthonous tumor cell vaccine in canine lymphoma.
    Jeglum KA; Young KM; Barnsley K; Whereat A; McGrath D; Hutson C
    J Biol Response Mod; 1986 Apr; 5(2):168-75. PubMed ID: 3734843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles of treatment for canine lymphoma.
    Ettinger SN
    Clin Tech Small Anim Pract; 2003 May; 18(2):92-7. PubMed ID: 12831068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II evaluation of doxorubicin for treatment of various canine neoplasms.
    Ogilvie GK; Reynolds HA; Richardson RC; Withrow SJ; Norris AM; Henderson RA; Klausner JS; Fowler JD; McCaw D
    J Am Vet Med Assoc; 1989 Dec; 195(11):1580-3. PubMed ID: 2599941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma.
    Keller ET; MacEwen EG; Rosenthal RC; Helfand SC; Fox LE
    J Vet Intern Med; 1993; 7(5):289-95. PubMed ID: 8263847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997).
    Zwahlen CH; Lucroy MD; Kraegel SA; Madewell BR
    J Am Vet Med Assoc; 1998 Oct; 213(8):1144-9. PubMed ID: 9787382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is maintenance chemotherapy appropriate for the management of canine malignant lymphoma?
    Hahn KA; Richardson RC; Teclaw RF; Cline JM; Carlton WW; DeNicola DB; Bonney PL
    J Vet Intern Med; 1992; 6(1):3-10. PubMed ID: 1548624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma.
    Moore AS; Cotter SM; Rand WM; Wood CA; Williams LE; London CA; Frimberger AE; L'Heureux DA
    J Vet Intern Med; 2001; 15(4):348-54. PubMed ID: 11467592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.